BridgeMD
New treatment option for Atrial Fibrillation
Official title Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patients With Structural Heart Disease
ClinicalTrials.gov ID: NCT06556732
What this study is testing
What is Eplereone?
Eplereone is an investigational medicine, given as an once-daily, being studied as a potential treatment for atrial fibrillation.
Also referred to as Amiodarone.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a prospective comparative study, conducted at Cardiology Department, Aswan University Hospital on AF patients with structural heart disease. Eplerenone 25 mg daily will be given and searching for AF recurrence among study population.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 70. Healthy volunteers may be eligible.
You may be able to join if
- Patients with non-valvular AF who underwent cardioversion to sinus rhythm either medical, electrical or even spontaneously
You likely can't join if
- Patients with rheumatic heart disease.
- Thyroid dysfunction.
- Wolf-Parkinson-White (WPW) syndrome.
- Renal impairment.
- Hyperkalemia.
- Acute coronary syndrome.
See the full eligibility criteria
- Patients with non-valvular AF who underwent cardioversion to sinus rhythm either medical, electrical or even spontaneously
- Patients with rheumatic heart disease.
- Thyroid dysfunction.
- Wolf-Parkinson-White (WPW) syndrome.
- Renal impairment.
- Hyperkalemia.
- Acute coronary syndrome.
- Pregnancy.
- Left ventricular (LV) dysfunction with ejection fraction (EF) less than 40%.
- On current use of eplerenone.
The study team makes the final eligibility decision.
Where it's taking place
- Asyut, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Asyut, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.